bpc-157 evidence safety for athletes and injury treatment: Science, safety, and legal concerns bpc-157 human clinical trials evidence

He also served as a compensated consultant on advisory committees for Alnylam, Amgen, Boehringer Ingelheim, Fractyl and Novo Nordisk, and a volunteer uncompensated consultant on advisory committees for Boehringer Ingelheim, Jazz Pharmaceuticals, Novo Nordisk and Pfizer

AnsteeQMDarlayRCockellSMeroniMGovaereOTiniakosDet al

Core Principles IV NAD: high dose, infrequent, best for initial loading and occasional maintenance SQ NAD: moderate dose, frequent, great for bridging between IV sessions Oral NAD: Daily dose, steady baseline support Pre-Week 1 Before you even receive your first IV, we recommend you start with NR or NMN oral pills at around 250mg to prime your system before any parenteral dosing

Until safety data exists, avoiding use during these periods is the only prudent approach